Literature DB >> 20100802

The novel mouse Polo-like kinase 5 responds to DNA damage and localizes in the nucleolus.

Zdenek Andrysik1, William Z Bernstein, Li Deng, David L Myer, Ya-Qin Li, Jay A Tischfield, Peter J Stambrook, El Mustapha Bahassi.   

Abstract

Polo-like kinases (Plk1-4) are emerging as an important class of proteins involved in many aspects of cell cycle regulation and response to DNA damage. Here, we report the cloning of a fifth member of the polo-like kinase family named Plk5. DNA and protein sequence analyses show that Plk5 shares more similarities with Plk2 and Plk3 than with Plk1 and Plk4. Consistent with this observation, we show that mouse Plk5 is a DNA damage inducible gene. Mouse Plk5 protein localizes predominantly to the nucleolus, and deletion of a putative nucleolus localization signal (NoLS) within its N-terminal moiety disrupts its nucleolar localization. Ectopic expression of Plk5 leads to cell cycle arrest in G1, decreased DNA synthesis, and to apoptosis, a characteristic it shares with Plk3. Interestingly, in contrast to mouse Plk5 gene, the sequence of human Plk5 contains a stop codon that produces a truncated protein lacking part of the kinase domain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20100802      PMCID: PMC2875007          DOI: 10.1093/nar/gkq011

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  69 in total

1.  Incomplete cytokinesis and induction of apoptosis by overexpression of the mammalian polo-like kinase, Plk3.

Authors:  C W Conn; R F Hennigan; W Dai; Y Sanchez; P J Stambrook
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

Review 2.  Controlling the end of the cell cycle.

Authors:  L Cerutti; V Simanis
Journal:  Curr Opin Genet Dev       Date:  2000-02       Impact factor: 5.578

3.  p107 is active in the nucleolus in non-dividing human granulosa lutein cells.

Authors:  C Green; R Chatterjee; H H McGarrigle; F Ahmed; N S Thomas
Journal:  J Mol Endocrinol       Date:  2000-12       Impact factor: 5.098

4.  Essential function of the polo box of Cdc5 in subcellular localization and induction of cytokinetic structures.

Authors:  S Song; T Z Grenfell; S Garfield; R L Erikson; K S Lee
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

5.  In vivo localisation of the mitotic POLO kinase shows a highly dynamic association with the mitotic apparatus during early embryogenesis in Drosophila.

Authors:  T Moutinho-Santos; P Sampaio; I Amorim; M Costa; C E Sunkel
Journal:  Biol Cell       Date:  1999-11       Impact factor: 4.458

6.  Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization.

Authors:  H Rizos; A P Darmanian; G J Mann; R F Kefford
Journal:  Oncogene       Date:  2000-06-15       Impact factor: 9.867

7.  Peripheral Golgi protein GRASP65 is a target of mitotic polo-like kinase (Plk) and Cdc2.

Authors:  C Y Lin; M L Madsen; F R Yarm; Y J Jang; X Liu; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

8.  The contribution of the RING finger domain of MDM2 to cell cycle progression.

Authors:  M Argentini; N Barboule; B Wasylyk
Journal:  Oncogene       Date:  2000-08-10       Impact factor: 9.867

9.  Polo-like kinase-1 is a target of the DNA damage checkpoint.

Authors:  V A Smits; R Klompmaker; L Arnaud; G Rijksen; E A Nigg; R H Medema
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

10.  Sak kinase gene structure and transcriptional regulation.

Authors:  J W Hudson; L Chen; C Fode; C Binkert; J W Dennis
Journal:  Gene       Date:  2000-01-04       Impact factor: 3.688

View more
  32 in total

1.  The Polo-like kinase PLKA in Aspergillus nidulans is not essential but plays important roles during vegetative growth and development.

Authors:  Klarita Mogilevsky; Amandeep Glory; Catherine Bachewich
Journal:  Eukaryot Cell       Date:  2011-12-02

2.  Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo.

Authors:  Juping Yuan; Mourad Sanhaji; Andrea Krämer; Wolfgang Reindl; Matthias Hofmann; Nina-Naomi Kreis; Brigitte Zimmer; Thorsten Berg; Klaus Strebhardt
Journal:  Am J Pathol       Date:  2011-08-10       Impact factor: 4.307

Review 3.  Polo-like kinases: structural variations lead to multiple functions.

Authors:  Sihem Zitouni; Catarina Nabais; Swadhin Chandra Jana; Adán Guerrero; Mónica Bettencourt-Dias
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07       Impact factor: 94.444

4.  The DNA damage effector Chk1 kinase regulates Cdc14B nucleolar shuttling during cell cycle progression.

Authors:  Sirisha Peddibhotla; Zhubo Wei; Rao Papineni; Micheal H Lam; Jeffrey M Rosen; Pumin Zhang
Journal:  Cell Cycle       Date:  2011-02-15       Impact factor: 4.534

Review 5.  Understanding the Polo Kinase machine.

Authors:  V Archambault; G Lépine; D Kachaner
Journal:  Oncogene       Date:  2015-01-26       Impact factor: 9.867

Review 6.  Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy.

Authors:  Klaus Strebhardt
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

Review 7.  Polo-like kinase 1, on the rise from cell cycle regulation to prostate cancer development.

Authors:  Jijing Luo; Xiaoqi Liu
Journal:  Protein Cell       Date:  2012-03-23       Impact factor: 14.870

Review 8.  Polo-like kinase 3, hypoxic responses, and tumorigenesis.

Authors:  Dazhong Xu; Wei Dai; Cen Li
Journal:  Cell Cycle       Date:  2017-09-21       Impact factor: 4.534

9.  Plk2 regulates mitotic spindle orientation and mammary gland development.

Authors:  Elizabeth Villegas; Elena B Kabotyanski; Amy N Shore; Chad J Creighton; Thomas F Westbrook; Jeffrey M Rosen
Journal:  Development       Date:  2014-03-05       Impact factor: 6.868

10.  Differential expression of AURKA/PLK4 in quiescence and senescence of osteosarcoma U2OS cells.

Authors:  Xiao-Liang Xie; Hai-Xia Zhu; Yu-Mei Li; De-Ta Chen; Tian-You Fan
Journal:  Cell Cycle       Date:  2020-03-21       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.